Chemotherapy of mice bearing syngeneic tumors with 1,3-bis (2-chloroethyl)-1-nitrosourea is effective only in normal, but not in irradiated or nude, mice: Role of L3T4+ (CD4+) and Lyt-2+ (CD8+) T cells

This publication has 22 references indexed in Scilit:

• Therapy of disseminated murine leukemia with cyclophosphamide and immune Lyt-1+,2- T cells. Tumor eradication does not require participation of cytotoxic T cells.
  The Journal of Experimental Medicine, 1985
• T-cell subsets in tumour rejection responses
  Immunology Today, 1985
• Effect of in vivo administration of Lyt antibodies. Lyt phenotype of T cells in lymphoid tissues and blocking of tumor rejection.
  The Journal of Experimental Medicine, 1985
• Generation and decay of the immune response to a progressive fibrosarcoma. II. Failure to demonstrate postexcision immunity after the onset of T cell-mediated suppression of immunity.
  The Journal of Experimental Medicine, 1984
• Generation and decay of the immune response to a progressive fibrosarcoma. I. Ly-1+2- suppressor T cells down-regulate the generation of Ly-1-2+ effector T cells.
  The Journal of Experimental Medicine, 1984
• A reexamination of the role of LYT-2-positive T cells in murine skin graft rejection.
  The Journal of Experimental Medicine, 1984
• Expression of passively transferred immunity against an established tumor depends on generation of cytolytic T cells in recipient. Inhibition by suppressor T cells.
  The Journal of Experimental Medicine, 1983
• Cells mediating graft rejection in the mouse. I. Lyt-1 cells mediate skin graft rejection.
  The Journal of Experimental Medicine, 1981
• Elimination of syngeneic sarcomas in rats by a subset of T lymphocytes.
  The Journal of Experimental Medicine, 1980
• A rapid method for the isolation of functional thymus‐derived murine lymphocytes
  European Journal of Immunology, 1973